The U.S. Department of Health and Human Services (HHS), Office of Research Integrity is seeking input from individuals, research funding agencies, institutional officials, organizations, institutions,...
Read The ArticleThe U.S. Food and Drug Administration (FDA) has approved bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines as a single booster dose. See the...
Read The Article“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...
Read The ArticleCITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for...
Read The ArticleThe U.S. Food and Drug Administration (FDA) issued a revised draft guidance, entitled Charging for Investigational Drugs Under an IND Questions and Answers. When finalized,...
Read The Article“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...
Read The ArticleIntroduction Clinical and research environments may be host to a variety of biohazards. These environments include clinical and microbiological laboratories; biomedical research and biotechnology facilities;...
Read The Article“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...
Read The ArticleCITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for...
Read The ArticleThe Council of Governmental Relations (COGR) has released the second version of the report Technology Transfer in U.S. Research Universities: Dispelling Common Myths, initially released...
Read The Article
